Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4860927
Max Phase: Preclinical
Molecular Formula: C21H20F2N6
Molecular Weight: 394.43
Molecule Type: Unknown
Associated Items:
ID: ALA4860927
Max Phase: Preclinical
Molecular Formula: C21H20F2N6
Molecular Weight: 394.43
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3cc(F)ccc23)n[nH]1
Standard InChI: InChI=1S/C21H20F2N6/c1-3-16-11-19(29-28-16)26-20-17-9-8-15(23)10-18(17)25-21(27-20)24-12(2)13-4-6-14(22)7-5-13/h4-12H,3H2,1-2H3,(H3,24,25,26,27,28,29)/t12-/m0/s1
Standard InChI Key: KEIROKXBRBGGGJ-LBPRGKRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 394.43 | Molecular Weight (Monoisotopic): 394.1718 | AlogP: 5.11 | #Rotatable Bonds: 6 |
Polar Surface Area: 78.52 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.91 | CX Basic pKa: 4.90 | CX LogP: 5.66 | CX LogD: 5.66 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.42 | Np Likeness Score: -1.49 |
1. Uehling DE, Joseph B, Chung KC, Zhang AX, Ler S, Prakesch MA, Poda G, Grouleff J, Aman A, Kiyota T, Leung-Hagesteijn C, Konda JD, Marcellus R, Griffin C, Subramaniam R, Abibi A, Strathdee CA, Isaac MB, Al-Awar R, Tiedemann RE.. (2021) Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma., 64 (15.0): [PMID:34291633] [10.1021/acs.jmedchem.1c00506] |
Source(1):